Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Rapid Pathogen Screening Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010965
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tests. Its product portfolio includes AdenoPlus, a CLIA-waived, point-of-care test that identifies serotypes of adenoviral conjunctivitis; and the InflammaDry test for dry eye. Rapid Pathogen’s FebriDx test helps to identify pathogen induced immune response to viral and bacterial acute febrile respiratory infection. The company develops solutions for infectious diseases and inflammatory conditions. It also offers bio-terrorism and chemical nerve agent blood toxin solutions. Rapid Pathogen is headquartered in Sarasota, Florida, the US.

Rapid Pathogen Screening Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rapid Pathogen Screening Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
Rapid Pathogen Screening Raises US$5.2 Million In Venture Financing 14
Partnerships 15
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 15
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Asset Transactions 18
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc – Key Competitors 19
Rapid Pathogen Screening Inc – Key Employees 20
Rapid Pathogen Screening Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Rapid Pathogen Screening Inc, Medical Equipment, Key Facts 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rapid Pathogen Screening Inc, Deals By Market, 2011 to YTD 2017 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
Rapid Pathogen Screening Raises US$5.2 Million In Venture Financing 14
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 15
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc, Key Competitors 19
Rapid Pathogen Screening Inc, Key Employees 20

★海外企業調査レポート[Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Healthcare Berhad (AHEALTH):企業の財務・戦略的SWOT分析
    Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Groupe Sodiaal:企業の戦略・SWOT・財務情報
    Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report Summary Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mitsubishi Heavy Industries Ltd (7011):企業の財務・戦略的SWOT分析
    Mitsubishi Heavy Industries Ltd (7011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Eagle Materials Inc (EXP):企業の財務・戦略的SWOT分析
    Eagle Materials Inc (EXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Resources Land Limited:戦略・SWOT・企業財務分析
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Laredo Petroleum Inc (LPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Laredo Petroleum Inc (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company h …
  • University Hospital of Lyon-製薬・医療分野:企業M&A・提携分析
    Summary University Hospital of Lyon (HCL) is a healthcare service provider that offers patient care and educational services. The hospital provides care, education, research and medical innovation, prevention and health training services. It provides human, technical and logistical resources for mat …
  • Quest Diagnostics Incorporated:戦略・SWOT・企業財務分析
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • ABO Wind AG-エネルギー分野:企業M&A・提携分析
    Summary ABO Wind AG (ABO Wind) develops renewable energy projects in Europe. The company carries out the planning and environmental impact assessment, design, development, and operation of wind power projects and biomass power generating facilities. ABO Wind also provides long-term management or mai …
  • FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary FirstString Research Inc (FirstString) is a biopharmaceutical company that discovers and develops therapies for inflammation and injury based medical conditions. The company markets new therapeutic products that enable physicians to treat unmet medical need. It offers therapeutic approach, w …
  • Perenco Holdings-石油・ガス分野:企業M&A・提携分析
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • True Value Company:企業の戦略・SWOT・財務情報
    True Value Company - Strategy, SWOT and Corporate Finance Report Summary True Value Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Active Motif Inc:医療機器:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Northstar Aerospace Inc.:企業の戦略・SWOT・財務情報
    Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • APRIL Group S.A. (APR):企業の財務・戦略的SWOT分析
    APRIL Group S.A. (APR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Golar LNG Ltd (GOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Golar LNG Limited (Golar LNG) is a midstream liquefied natural gas (LNG) company. It provides liquefaction, transport, storage, and re-gasification services to customers in the LNG industry. The company owns and operates LNG carriers and FSRUs; and develops FLNGVs. Through a joint venture wi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆